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Abstract: Ortho- and para-substituted aminophenyl benzothiazoles were synthesized and characterized using NMR spectroscopy. A comparison 
of the proton chemical shift values reveals significant differences in the observed chemical shift values for the NH protons indicating the 
presence of a hydrogen bond in all ortho-substituted compounds as compared to the para compounds. The presence of intramolecular hydrogen 
bond in the ortho amino substituted aminophenyl benzothiazole forces the molecule to be planar which may be an additional advantage in 
developing these compounds as Alzheimer’s imaging agent since the binding to amyloid fibrils prefers planar compounds. The splitting pattern 
of the methylene proton next to the amino group also showed significant coupling to the amino proton consistent with the notion of the existence 
of slow exchange and hydrogen bond in the ortho-substituted compounds. This is further verified by density functional theory (DFT) 
calculations which yielded a near planar low energy conformer for all the o-aminophenyl benzothiazoles and displayed a hydrogen bond from 
the amine proton to the nitrogen of the thiazole ring. A detailed analysis of the 1H, 13C, and 15N NMR chemical shifts and DFT calculated 
structures of the compounds are described. 
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Introduction: Aminophenyl benzothiazoles are a unique class of compounds possessing extraordinary biological activity. In recent years, 
attention has been focused on the development of novel derivatives of aminophenyl benzothiazoles to utilize them as biologically useful 
compounds.[1, 2] Stevens et al.[3-5] have extensively studied these compounds for their anticancer properties. The cytotoxicity profiles of 
polyhydroxylated 2-phenyl benzothiazoles against human tumor cell lines compared well with Genistein and the benzothiazoles acted as tyrosine 
kinase inhibitors similar to Genistein and other known flavones. Several aminophenyl benzothiazole derivatives have been reported.[6] 
Interestingly, introduction of groups at the 3’ position of the phenyl moiety enhanced the potency of the compounds and derivatives with methyl, 
chloro, bromo and iodo groups in that position showed unprecedented activity against several tumor cell lines. In light of the biological activity 
of benzothiazole derivatives, other applications have been explored including possible application as a diagnostic agent in Alzheimer’s disease. 
The progressive neuronal loss associated with this disease is believed to occur due to the formation of senile plaques and neurofibrillary tangles 
within the brain. Several studies have implicated a short peptide containing 39-43 amino acids as the main constituent of amyloid plaques [7-8]. 
These are produced by the proteolytic cleavage of a precursor protein by secretases [9] to form insoluble fibrils that deposit in the brain. Todd et 
al.[10] has reported a comprehensive review on the development and application of various compounds for amyloid imaging. Aminophenyl 
benzothiazoles have been highlighted as ideal candidates for brain imaging. The [11C]-6-Me-benzothiazole has been prepared by methylation of 
4-(6-methyl-2-benzothiazolyl) aniline using [11C] methyl iodide.[11] Additional modification by removing the 6-methyl group in the structure 
gave [11C] BTA ((N-methyl-[11]C)-2-(4'-(methylaminophenyl)-benzothiazole) which showed improved uptake and washout characteristics in 
normal mice. It also showed vivo specificity towards amyloid fibrils in the brain of transgenic mouse models of Alzheimer Disease and human 
AD brain homogenates.[11,12] The 6-hydroxy substituted amino methyl benzothiazole derivative is also known as Pittsburgh Compound B (PIB) 
[13-17] and has received Federal Drug Administration approval as an imaging contrast agent for Alzheimer’s Disease. Although the 4-
aminophenyl benzothiazoles have been studied extensively, the synthesis and characterization of the o-aminophenyl benzothiazole derivatives 
has not been extensively described and is the subject of this paper. The compounds we studied were 2-(4’-aminophenyl)benzothiazole (4’-
(benzo[d]thiazole-2yl)aniline) (1) and 2-(2’-aminophenyl) benzothiazole (2’-(benzo[d]thiazole-2yl)aniline) (8) analogs (Table 1). The 
compounds throughout this manuscript will be referred to as aminophenyl benzothiazoles. We include analysis of the structure using DFT 
calculations. The aim for studying the structural feature of ortho aminophenyl substituted benzothiazole is to investigate whether the hydrogen 
bond formation helps to further stabilize the molecule due to planarity. This aspect is important in terms of utility of these compounds as 
Alzheimer’s imaging agents, since all the known imaging agents (thioflavin T derivatives) are planar which aids the binding of these molecule to 
amyloid fibrils.[18-20] Recently, Petric et al.[21] reported the binding affinities of two planar molecules of dicyanovinyl naphthalenes for 
neuroimaging of amyloid and came to the conclusion that the most planar analogs showed the highest binding affinities towards amyloid while 
the least planar analog showed lowest binding affinity. 
 
Experimental: All the chemicals were obtained from Sigma Aldrich and were used without further purification. NMR spectra were recorded in 
deuterated chloroform and the chemical shifts for protons are reported relative to the residual chloroform signal at 7.25 ppm. The NMR data 
were acquired on a Bruker 900 MHz NMR spectrometer equipped with a cryoprobe. The proton spectra were acquired with a sweep width of 12 
ppm centred at 5 ppm. The carbon spectra were acquired with a sweep width of 200 ppm centred at 105 ppm. The residual chloroform peak at 77 
ppm was used as a 13C chemical shift reference. The COSY experiments were acquired with a sweep width of 12 ppm using a 90° pulse of 9 µs 
with 128 increments respectively. The 13C HSQC spectra were acquired with sweep widths of 12 and 200 ppm for proton and carbon 
respectively and the carbon centred at 100 ppm. Additionally HMBC spectral data were also acquired to establish the structures of the 
compounds (13C sweep width of 200 ppm). The 15N spectra were acquired using a sweep width of 400 ppm and urea was used as external 
standard at 73.4 ppm. 
The synthesis of the o-substituted aminophenyl benzothiazole was accomplished by following the synthetic scheme in Figure 1. 
In brief, o-amino thiophenol was condensed with o-aminobenzoic acid in polyphosphoric acid at 220⁰C to furnish the o-aminophenyl 
benzothiazole. This was further alkylated using alkyl bromide/iodide in the presence of potassium carbonate and acetonitrile to yield the desired 
products. A detailed description of synthesis and isolation of the products will be reported elsewhere.[22] The para-substituted aminophenyl 
benzothiazoles were prepared in a similar fashion using 4-aminobenzoic acid instead of o-aminobenzoic acid. Several mono alkylated amino 
derivatives were prepared and their melting points (⁰C) are: (1):156-157;(2):166-167; (3):127-128; (5):119-120; (6):137-138; (7):126-127; 
(8)128-130; (9):11-112; (10):61-62; (11):81-82; (12):71-72; (13):93-94; (14):128-130. 
Molecular Modelling: Monte Carlo Conformational searching was performed using Macromodel V10.1 (Schrodinger, LLC, New York).[23] 
Torsional sampling (MCMM) was performed with 1000 steps per rotatable bond. Each step was minimised with the OPLS-2005 force field 
using the TNCG method with maximum iterations of 50,000 and energy convergence threshold of 0.02. All other parameters were left as the 
default values. All low energy conformations (< 5 kcal/mol from global minimum, were further optimised using DFT calculations in Jaguar 
V8.1, (Schrödinger, LLC, New York).[24] (B3LYP/6-311++G(d,p), with chloroform solvent). 
Results and Discussion:  
Tables 2 and 3 show the 1H NMR chemical shifts observed for the para- and ortho-substituted aminophenyl benzothiazoles in deuterated 
chloroform at room temperature respectively. Compound 1 which is the parent para amino substituted derivative showed a broad singlet at 4.0 
ppm corresponding to the free amino group in the structure. The NMR spectrum further showed four doublets and two triplets associated with 
the aromatic protons. Compound 2 showed the methyl resonance at 2.90 ppm as a singlet and the NH protons appeared at 4.12 ppm as a broad 
singlet and all other proton signals were consistent with the structure. The comparison of the 1H NMR chemical shifts of all the p-aminophenyl 
substituted derivatives showed that the aromatic signals were almost identical. This is expected because there is no significant change in the 
main structural frame of the compounds. As expected the methyl signal from compound 2 appeared as a singlet and the methylene signal of other 
compounds in the series showed the expected splitting patterns due to coupling to the adjacent protonated carbons (Figure 2). 
The 1H NMR chemical shifts for the o-aminophenyl substituted benzothiazole (compound 8) showed the NH2 proton as a broad singlet at 6.4 
ppm. Comparing this NH2 proton with compound 1 described in the previous paragraph, it is evident that the o-aminophenyl substituted 
compound showed a downfield shift of nearly 2.40 ppm compared to p-aminophenyl substituted compound 1, indicating that this proton is in 
slow exchange and is possibly involved in a hydrogen bond with the thiazole moiety. There are two positions in the thiazole ring that contain 
heterocyclic atoms such as nitrogen or sulphur which could be involved in the hydrogen bond. On the basis of electronegativity differences 
among them, the most preferred is likely to be the nitrogen atom of the thiazole ring. The hydrogen bonded structure should yield a stable six 
membered ring. 
The formation of such intramolecular hydrogen bond has been proposed previously by Dey et al. [25] in dealing with the solvatochromism of 
aminophenyl benzothiazole derivatives. It was proposed that the lone pair of electrons associated with the nitrogen group is being forced to be 
parallel with the π-cloud, thereby altering the resonance characteristics. The formation of such an intramolecular hydrogen bond is expected to 
shift the resonance downfield and this was confirmed experimentally. Comparing the other chemical shift values between the aromatic proton 
resonances, we found that there was only a marginal change in the chemical shift values between the o-aminophenyl and the p-aminophenyl 
benzothiazole derivatives. 
Comparison of the chemical shift values between the N-methyl substituted derivatives (compounds 2 and 9) showed small changes in the methyl 
proton’s chemical shift value from 2.90 ppm to 3.04 ppm respectively. However, there was a significant change in the splitting pattern which 
changed from a singlet to a doublet (Figure 2). The doublet arises in compound 9 due to the coupling with the amino proton. The amino proton 
showed a significant change from 4.12 ppm to 8.79 ppm and from a very broad resonance to a broad peak with some structure resembling a 
quartet. This splitting pattern is expected since this proton is coupled to the methyl proton and further confirms that the amino proton is involved 
in a hydrogen bond with the proton in slow exchange. All other aromatic proton signals in the benzothiazole fragment were unchanged. 
The other substituted aminophenyl compounds showed a similar chemical shift change for the amino group from 3.90 – 4.12 ppm to 8.86 – 9.10 
ppm for the para- and ortho-substituted compounds respectively. All other aromatic proton signals in the benzothiazole fragment are very 
similar. All the para- compounds showed the expected splitting pattern but the ortho-substituted derivatives showed the extra splitting in the 
methylene multiplet adjacent to the amino group. Again, this is due to the coupling to the amino proton which is in slow exchange due to being 
involved in a hydrogen bond. Examples of the observed splitting pattern for the methylene proton for the para- and ortho-substituted compounds 
are shown in Figure 2. The coupling constant to the amino proton in the methyl, ethyl, propyl and butyl substituted compounds is 4.8 Hz, 
however it increases to 6.2 Hz in the isopropyl-substituted compound. The amino peak in the ortho-substituted compounds showed splitting 
associated with the coupling to the adjacent protons in the alkyl group (Figure 3) 
We then examined the carbon NMR chemical shifts of the compounds in chloroform solution (Tables 4 and 5).  Most of the carbon chemical 
shift values were very similar with no significant change in the chemical shift values with different alkyl groups. Additionally, there was no 
significant change in the chemical shift values of the benzothiazole carbons for the para- and ortho-substituted compounds. In summary, 
introduction of various alkyl groups in the amine functionality of the compounds had no significant effect on the carbon chemical shift values.  
The effect of various alkyl groups on 15N chemical shift values were examined (Table 6). Chemical shifts were determined by acquiring a 15N 
HMBC experiment. The 15N chemical shift for the thiazole ring nitrogen appeared at approximately 290 ppm in all compounds, and was usually 
much less intense than for the amine nitrogen. This was expected as changes in the structural characteristics of the benzothiazole moiety did not 
affect proton or carbon chemical shifts, as discussed previously. The 15N chemical shift of the amino group in the molecule was significantly 
affected by the alkyl substituent. For example, in the case of para-aminophenyl benzothiazole derivatives, compound 1 showed a chemical shift 
value of 58.9 ppm for the amino group. Increasing length of the alkyl side chain caused a deshielding of the NH chemical shifts. The chemical 
shift value was 57.6 ppm for the methyl-substituted derivative and ethyl, propyl and butyl and crotyl substitution showed a significant shift in the 
chemical shift values (73-76 ppm). The isopropyl substituted derivative showed the highest chemical shift value of 90.8 ppm perhaps owing to 
the dimethyl group in the structure of the compound.  
The 15N chemical shift values of the alkyl substituted o-aminophenyl benzothiazole revealed the following trend; compound 8 showed a 
chemical shift value of 65.2 ppm as compared to 58.9 ppm for the para amino substituted compound 1. The other compounds in the ortho series 
showed similar trend in chemical shift values (see Table 6) to that observed for the p-aminophenyl analogs. The isopropyl substituted compound 
again showed the highest chemical shift value of 95 ppm akin to that obtained for the para-substituted compound 6 (90.0 ppm). Duthaler et al. 
[26] have reported the effects of N-alkyl substituents upon the 15N chemical shifts of the aminic nitrogen. The increments on the chemical shift 
values satisfactorily apply to the effects observed in the present study. The chemical shift values did not follow a systematic trend as larger alkyl 
groups were introduced into the structure of aminophenyl benzothiazole compounds. Ortho-substituted derivatives had higher chemical shift 
values than the corresponding para-substituted derivatives. 
We then proceeded to investigate the structures of the compounds using molecular modelling. Firstly, the conformational space was investigated 
by performing a Monte Carlo conformational search using the MacroModel software (Schrodinger, LLC)[27] and then each conformation was 
further optimised by Jaguar (Schrodinger, LLC)[28] with the inclusion of chloroform solvent. The final structures were compared to eliminate any 
duplicate structures. After the macromodel conformational search, all the para substituted derivatives showed the two aromatic ring being in a 
planar arrangement and the N-H bond being in-plane to the phenyl ring. On the other hand, the ortho substituted derivatives had a non-planar 
arrangement of the aromatic rings from 40-80⁰ and none of the compounds showed a hydrogen bond to the nitrogen or the sulphur. From the 
DFT calculations, the p-aminophenyl benzothiazole (compound 1) showed one planar conformer due to the symmetry of the molecule. The 
angle between the thiazole and phenyl ring was 1.3⁰ and the amine had a planar arrangement with respect to the phenyl ring due to delocalisation 
of the nitrogen lone pair. 
The o-aminophenyl benzothiazole derivative (compound 8) resulted in two conformers. The lowest energy conformer had an angle between the 
benzothiazole and the phenyl ring of 1.6⁰, which was significantly different to that predicted by the molecular mechanics calculation. The N-H 
bond was almost coplanar with the phenyl ring at 8.9⁰. The conformation resulted in a hydrogen bond between the NH proton and the nitrogen 
atoms of the thiazole ring, in agreement with proton NMR results. The second conformer was found to have an angle between the benzothiazole 
ring and the phenyl ring of 34.1⁰ and the N-H bond was 16.8⁰ out of the plane of the phenyl ring.  The Boltzmann population distribution of 
these two conformers was calculated to be 99.92:0.08 indicating that the hydrogen bonded conformer was almost exclusively preferred.  
For compound 9 (NHMe), conformational searching and further optimization with Jaguar yielded similar results. The p-methylamino compound 
(2) had two conformers due to rotation around the C-N bond. The benzothiazole to phenyl ring angle of 1.3⁰ was very close to a planar 
configuration. The NH bond was out of plane by only 0.4⁰. The Boltzmann population distribution between these two conformers was almost 
50:50. The o-methylamino substituted compound (9) had five conformers, the lowest of which was near planar with an angle between the 
benzothiazole and phenyl rings of 0.5⁰ and an N-H bond that was only 0.1⁰ out of plane with the phenyl ring. This conformer also resulted in a 
hydrogen bond between the NH proton and the thiazole nitrogen. The other four conformers where not in a planar arrangement and did not form 
the hydrogen bond. From the energies the Boltzmann population distribution of the lowest energy conformer versus the four other conformations 
was 99.98:0.02. The results are in keeping with observed NMR chemical shift values for the amino proton which provide evidence of hydrogen 
bonding. Figure 4 shows the DFT optimized structures of the o-methylaminophenyl benzothiazole (9). For the p-ethylamino compound (3) 
resulted in four conformations due to rotamers within the ethyl chain. The lowest energy conformation represented 42.6% of the Boltzmann 
population. The lowest three energy conformation had a near planar aromatic substructure (< 1.1⁰) and the N-H bond of the amino group was 
planar with the phenyl ring in the top two structures. 
The o-ethylamino compound (10) resulted in 16 conformers, of which five were hydrogen bonded to the nitrogen atom in the thiazole ring. 
These 5 conformers comprised 99.98% of the Boltzmann population, the lowest energy conformer contributing 41.3% of the room temperature 
population. The latter was a planar structure with the N-H bond being out of plane by only 0.5⁰. The other four structures had benzothiazole to 
phenyl ring angles of 0.3⁰–2.3⁰ with the N-H bond being out of plane by 2.8-3.7⁰. 
The p-propylamino compound (4) resulted in ten conformers due to the rotation of the propyl side chain. Of the rotamers, five showed the N-H 
bond parallel to the phenyl ring while the remainder showed the N-H bond antiparallel (i.e. 180o in the opposite direction) due to rotation about 
the C-N bond. 
Optimization of the structure of the o-propylamino compound (11) using Jaguar resulted in 28 conformations. The six lowest energy conformers 
showed a hydrogen bond between the NH group and the nitrogen atom of the thiazole. These conformers contributed 99.97% of the Boltzmann 
population. In the lowest energy conformers, the benzothiazole ring and the phenyl ring were out of plane slightly by 0.7o. The N-H bond for the 
amino group was 0.5o out of plane with the phenyl ring. This resulted in a planar conformation due to the formation of the hydrogen bond and is 
consistent with the NMR data.  
Conclusions: In summary we have prepared several ortho- and para-aminophenyl benzothiazole derivatives and characterized them using 1H, 
13C, and 15N NMR spectroscopy. The data revealed that there were only marginal changes in the aromatic proton chemical shift in the para and 
ortho series of compounds. However the NH proton chemical shifts varied significantly between the para and ortho compounds due to the 
formation of a hydrogen bond between the NH group and the nitrogen in thiazole ring. Additionally, we observed significant changes in the 
splitting patterns for the CH/CH2 groups in the structure of the o-aminophenyl benzothiazoles. This is in contrast to that obtained for the p-
aminophenyl benzothiazole derivatives and it is rationalized due to the slow exchange of hydrogen due to the hydrogen bond. The presence of 
intramolecular hydrogen bond in o-aminophenyl benzothiazole derivatives may aid the binding of these compounds towards amyloid fibrils due 
to their resulting planar conformation. DFT calculations provided further evidence regarding the number of conformers for each of the 
molecules. When the hydrogen bond was present, the energy was reduced in conformers which comprised >99% of the Boltzmann population. 
The conformational search of para-substituted compounds did not show the presence of any hydrogen bonds. DFT calculations were consistent 
with the observed NMR chemical shifts. 
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Table 1. Structure numbering scheme and IUPAC names for the synthesised compounds 
Compound number (IUPAC name)  R group  Compound number (IUPAC name) 
S
N
NHR
1
233a'
4
5 67'
7a' 1'
2'
3'4'
5'
6'
 
 
 
1 (4‐(benzo[d]thiazole‐2’‐yl)aniline)  ‐H  8 (2‐(benzo[d]thiazole‐2’‐yl)aniline) 
2 (4‐(benzo[d]thiazole‐2’‐yl)‐N‐
methylaniline) 
‐CH3  9 (2‐(benzo[d]thiazole‐2’‐yl)‐N‐
methylaniline) 
3 (4‐(benzo[d]thiazole‐2’‐yl)‐N‐
ethylaniline) 
‐CH2CH3  10 (2‐(benzo[d]thiazole‐2’‐yl)‐N‐
ethylaniline) 
4 (4‐(benzo[d]thiazole‐2’‐yl)‐N‐
propylaniline) 
‐ CH2CH2CH3  11 (2‐(benzo[d]thiazole‐2’‐yl)‐N‐
propylaniline) 
5 (4‐(benzo[d]thiazole‐2’‐yl)‐N‐
butylaniline) 
‐ CH2CH2CH2CH3  12 (2‐(benzo[d]thiazole‐2’‐yl)‐N‐
butylaniline) 
6 (4‐(benzo[d]thiazole‐2’‐yl)‐N‐
isoropylaniline) 
‐CH(CH3)2  13 (2‐(benzo[d]thiazole‐2’‐yl)‐N‐
isoropylaniline 
7 (4‐(benzo[d]thiazole‐2’‐yl)‐N‐(but‐2’’‐en‐
1’’‐yl)aniline) 
‐CH2CH=CHCH3  14 (2‐(benzo[d]thiazole‐2’‐yl)‐N‐(but‐2’’‐
en‐1’’‐yl)aniline) 
 
Table 2. 1H NMR chemical shifts of p-aminophenyl benzothiazoles (1-7), in CDCl3 . 
 
Proton 1[29,30]  2  3  4  5  6  7  
2 6.72 (d, 1H, J=8.5) 6.64 (d, 1H, J=8.6) 6,64 (d, 1H, J=7.4) 6,63 (d, 1H, J=8.6) 6.63 (d, 1H, J=8.6) 6.61 (d, 1H, J=8.4) 6.64 (d, 1H, J=8.5) 
3 7.88 (d, 1H,J=8.3) 7.92 (d, 1H, J=8.6) 7.91 (d, 1H, J=8.6) 7.90 (d, 1H, J=8.6) 7.90 (d, 1H, J=8.6) 7.89 (d, 1H, J=8.4) 7.90 (d, 1H, J=8.5) 
5 7.88 (d, 1H, J=8.3) 7.92 (d, 1H, J=8.6) 7.91 (d, 1H, J=8.6) 7.90 (d, 1H, J=8.6) 7.90 (d, 1H, J=8.6) 7.89 (d, 1H, J=8.4) 7.90 (d, 1H, J=8.5) 
6 6.72 (d, 1H, J=8.5) 6.64 (d, 1H, J=8.6) 6.64 (d, 1H, J=7.4) 6.63 (d, 1H, J=8.6) 6.63 (d, 1H, J=8.6) 6.61 (d, 1H, J=8.4) 6.64 (d, 1H, J=8.5) 
4’ 7.99 (d, 1H, J=8.2) 7.98 (d, 1H, J=8.1) 7.98 (d, 1H, J=8.2) 7.96 (d, 1H, J=8.0) 7.97 (d, 1H, J=8.1) 7.97 (d, 1H, J=8.0) 7.97 (d, 1H, J=8.4) 
5’ 7.43 (t, 1H, J=7.75) 7.43 (t, 1H, J=7.5) 7.42 (t, 1H, J=7.98) 7.42 (t, 1H, J=7.5) 7.42 (t, 1H, J=7.5) 7.42 (t, 1H, J=7.6) 7.42 (t, 1H, J=7.5) 
6’ 7.31 (t, 1H, J=7.55) 7.30 (t, 1H, J=7.4) 7.30 (t, 1H, J=7.6) 7.29 (t, 1H, J=7.6) 7.29 (t, 1H, J=7.5) 7.29 (t, 1H, J=7.4) 7.30 (t, 1H, J=7.5) 
7’ 7.84 (d,1H, J=7.7) 7.83 (d, 1H, J=7.8) 7.82 (d, 1H, J=7.6) 7.83 (d, 1H, J=7.9) 7.83 (d, 1H, J=7.7) 7.83 (d, 1H, J=7.9) 7.83 (d, 1H, J=7.8) 
1’’ 4.0 (bs, 2H) 4.12 (bs, 1H) 4.0 (bs,1H) 4.04 (bs, 1H) 4.04 (bs, 1H) 3.90 (bs, 1H) 4.10 (bs,1H) 
2’’ - 2.90 (s, 3H) 3.23 (q, 2H, J=7.0) 3.16 (t, 2H, J=7.2) 3.18 (t, 2H, J=7.3) 3.71 (m, 1H) 3.75 (d, 2H, J=5.7) 
3’’ - - 1.29 ( t, 3H, J=7.0) 1.67 (m, 2H) 1.63 (m, 2H) 1.24 (d, 3H, J=6.4) 5.57 (m,1H) 
4’’ - - - 1.02 (t, 3H, J=7.5) 1.44 (m, 2H) 1.24 (d, 3H, J=6.4) 5.73 (m,1H) 
5’’ - - - - 0.97 (t, 3H, J=7.2) - 1.71 (d, 3H, J=6.4) 
Table 3. 1H NMR chemical shifts of o-aminophenyl benzothiazoles (8-14) in CDCl3 . 
 
Proton 8[31]  9  10 11  12  13  14  
3 7.70 (d, 1H,J=8.0) 7.73 (d, 1H, J=7.7) 7.74 (d, 1H, J=7.8) 7.72 (d, 1H, J=8.3) 7.72 (d, 1H, J=7.8) 7.72 (dd, 1H, J=7.8,1.4) 7.74 (d, 1H, J=7.6) 
4 6.74 (t, 1H,J=7.1) 6.69 (t, 1H, J=7.4) 6.69 (t, 1H, J=7.0)- 6.66 (t, 1H, J=7.0) 6.67 (t, 1H, J=7.4) 6.65 (t, 1H, J=7.5) 6.69 (t, 1H, J=6.4) 
6 6.78 (d, 1H, J=8.1) 6.77 (d, 1H, J=8.5) 6.79 (d, 1H, J=8.4) 6.78 (d, 1H, J=8.3) 6.78 (d, 1H, J=8.2) 6.79 (d, 1H, J=8.3) 6.78 (d, 1H, J=4.3) 
5 7.22 (t, 1H, J=7.1) 7.34 (t, 1H, J=7.7) 7.32 (t, 1H, J=7.8) 7.30 (t, 1H, J=7.6) 7.31 (t, 1H, J=7.8) 7.29 (t, 1H, J=7.7) 7.30 (t, 1H, J=7.6) 
4’ 7.97 (d, 1H, J=8.1) 7.96 (d, 1H, J=8.0) 7.96 (d,1H, J=8.0) 7.93 (d, 1H, J=8.3) 7.93 (d, 1H, J=8.0) 7.93 (d, 1H, J=7.8) 7.95 (d, 1H, J=8.0) 
5’ 7.45 (t, 1H,J=7.1) 7.44 (t, 1H, J=7.7) 7.45 (t, 1H, J=7.6) 7.43 (t, 1H, J=7.6) 7.44 (t, 1H, J=7.4) 7.43 (t, 1H, J=7.5) 7.44 (t, 1H, J=7.4) 
6’ 7.35 (t, 1H,J=7.7) 7.34 (t, 1H, J=7.5) 7.34 (t, 1H, J=7.4) 7.33 (t, 1H, J=7.5) 7.34 (t, 1H, J=7.6) 7.33 (t, 1H, J=7.5) 7.34 (t, 1H, J=7.4) 
7’ 7.87 (d, 1H, J=7.7) 7.85 (d, 1H, J=7.7) 7.86 (d, 1H, J=7.8) 7.85 (d, 1H, J=7.8) 7.86 (d, 1H, J=7.8) 7.85 (d, 1H, J=7.8) 7.85 (d, 1H, J=7.6) 
1’’ 6.40 (bs, 2H) 8.79 (bs, 1H) 8.86 (bs, 1H) 8.96 (bs, 1H) 8.96 (bs,1H) 8.94 (bs,1H) 9.1 (bs, 1H) 
2’’ - 3.04 (d, 3H) 3.38 (m, 2H, J=7.0) 3.29 (q, 2H, J=6.9) 3.32 (m, 2H) 3.82 (m, 1H) 3.93 (d, 2H, J=4.3) 
3’’ - - 1.46 ( t, 3H, J=7.2) 1.82 (m,2H) 1.79 (m,2H) 1.36 (d, 3H, J=6.3) 5.68 (m, 1H) 
4’’ - - - 1.12 (t, 3H, J=7.5) 1.54 (m,2H) 1.36 (d, 3H, J=6.3) 5.82 (m, 1H) 
5’’ - - - - 1.03 (t, 3H, J=7.5) - 1.78 (d, 3H, J=6.4) 
 
Table 4. 13C NMR Chemical shifts for p- aminophenyl benzothiazoles (1-7) in CDCl3 
carbon 1[29,30] 2  3  4  5  6  7  
1 149.2 151.6 150.7 150.8 150.8 149.8 150.6 
2 114.7 112.0 112.3 112.2 112.2 112.6 112.5 
3 129.6 129.1 129.2 129.1 129.1 129.2 129.1 
4 123.8 122.4 122.4 122.4 122.8 122.2 122.8 
5 129.6 129.1 129.2 129.1 129.1 129.2 129.1 
6 114.7 112.0 112.3 112.2 112.2 112.6 112.5 
2’ 168.5 168.4 168.8 168.8 168.8 168.7 168.9 
3a’ 154.2 154.2 154.1 154.4 154.3 154.3 154.5 
4’ 122.4 122.3 122.3 122.3 122.3 122.3 122.3 
5’ 126.0 126.0 126.0 126.0 126.0 125.9 126.0 
6’ 124.4 124.2 124.3 124.2 124.2 124.2 124.3 
7’ 121.4 121.3 121.4 121.3 121.3 121.3 121.4 
7a’ 134.5 134.4 134.4 134.5 134.5 134.5 134.6 
2’’ - 30.3 38.1 45.3 43.2 44.0 45.5 
3’’ - - 14.7 29.7 31.5 22.8 127.1 
4’’ - - - 11.6 20.2 22.8 128.6 
5’’ - - - - 13.9 - 17.8 
 
Table 5. 13C NMR chemical shifts for o-aminophenyl benzothiazoles (8-14) in CDCl3 . 
 
carbon 8[31]  9  10  11  12  13  14  
1 146.1 148.0 147.5 147.7 147.7 146.1 147.4
2 115.3 114.8 114.5 114.5 114.5 114.4 114.0
3 130.3 130.6 130.7 130.7 130.7 130.9 130.6
4 116.9 115.0 114.9 114.8 114.8 114.6 115.2
5 131.5 132.1 132.1 132.1 132.1 131.9 132.0
6 116.8 110.9 111.3 111.3 111.3 111.8 111.8
2’ 169.2 169.6 169.6 169.6 169.6 169.5 169.5
3a’ 153.7 153.6 153.6 153.6 153.6 153.6 153.5
4’ 122.4 122.2 122.2 122.2 122.2 122.2 122.3
5’ 126.0 125.9 125.9 125.9 125.9 125.9 126.0
6’ 124.8 124.7 124.7 124.7 124.7 124.7 125.0
7’ 121.2 121.1 121.1 121.1 121.1 121.0 121.1
7a’ 137.2 133.0 133.1 133.1 133.2 133.1 133.2
2’’ - 30.4 37.8 44.8 42.7 43.6 44.8 
3’’ - - 14.6 22.4 31.3 22.9 127.6
4’’ - - - 11.8 20.5 22.9 127.2
5’’ - - - - 14.0 - 17.8 
 
Table 6.15N NMR chemical shifts for p and o-aminophenyl benzothiazoles in CDCl3. 
 
Compound Para-substituted Ortho-substituted # NH-R ring N # NH-R ring N 
NH2 1 58.9 293.3 8 65.2 295.3 
NHCH3 2 57.6 289.6 9 61.7 291.7 
NHCH2CH3 3 76.3 * 10 79.8 293.3 
NHCH2CH2CH3 4 73.2 * 11 77.2 291.5 
NHCH2CH2CH2CH3 5 73.5 290.6 12 77.7 292.0 
CH(CH3)2 6 90.8 291.3 13 95.0 291.2 
CH2CH=CHCH3 (trans) 7 72.5 291.5 14 74.9 292.6 
 *not observable using the similar experimental conditions.
 
 
 
 
 
 Figure Captions 
 
Figure 1: Scheme illustrating the synthesis of p and o-aminophenyl alkyl substituted compounds 
 
Figure 2. Expansion of the methylene multiplet adjacent to the amino group for the para and ortho substituted compounds (the spectra are 
referenced so that all the peaks are aligned and slight resolution enhancement has been applied before FT). 
 
Figure 3. Expansion of the amino multiplet of the ortho compounds showing the splitting pattern (the spectra are referenced so that all the peaks 
are aligned and slight resolution enhancement has been applied before FT). 
 
Figure 4. DFT optimized structures of (o-methylamino phenyl) benzothiazole (9). a. Lowest energy planar structure and b. higher energy non-
planar structure. 
 
